This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

Conference Programme

Conference Programme

The 2022 Conference Programme is coming soon!

In the meantime, here are all the expert-led CPD certified sessions from our virtual event in June, for a flavour of what to expect in 2022!

Loading
09 Jun 2021
  1. Keynote
    Delivering our Long Term Plan commitments and completing the job of pandemic recovery are two sides of the same coin – both require cancers being identified faster and earlier, improving quality of li ...
  2. Keynote

    This session is sponsored and delivered by Teva UK Limited.

    Teva UK Limited have had no input into the speakers or content for the remaining agenda.

  3. Improving early detection and diagnosis
  4. Advanced cancer treatments and technologies
    Proton radiotherapy is a novel state of the art particle therapy and offers the opportunity to deliver highly targeted radiation, but we need to undertake research to understand who are the best candi ...
  5. Transforming cancer care pathways
    Active monitoring, or watch and wait, is used where cancer patients do not need immediate treatment. For the treatment of chronic lymphocytic leukaemia (CLL), this ensures treatment is given at the op ...
  6. Keynote
    Immuno-Oncology Therapies are delivering significant patient benefits across increasing tumour indications. However, rapidly growing demand, service variation, and managing immune reactions represent ...
  7. Advanced cancer treatments and technologies
    Until now no adjuvant or neoadjuvant therapies exist for non-metastatic renal cancer with a high risk of relapse. Previous studies using targeted therapy were not practice-changing. Immune checkpoint ...
  8. Transforming cancer care pathways
    In support of both earlier diagnosis and response to the covid-19 pandemic the Thames Valley cancer alliance launched the FIT (faecel immunochemical test) in primary care pathway. This session will ex ...
  9. Improving early detection and diagnosis
    •Highlight the challenges that cancer services face following COVID 19 disruption •Highlight the need to design bespoke AO services - no ‘one size fits all’ •Discuss the experience of using technology ...
  10. Improving early detection and diagnosis
    The session will discuss the lessons learnt from the South East London RDC to date. The session will look at the clinic set up, pathways, results to date and future goals.
  11. Advanced cancer treatments and technologies
  12. Keynote
    A discussion of the impact of CAT on cancer patients and the uneven approach to patient information seen in the national health system. The latest guidance recommendations and helpful tools to enhance ...
  13. Transforming cancer care pathways
    Providing patients with appropriate treatment options at the right time in their disease is key. Professor of Gastroenterology, Mark Pritchard and NET Clinical Nurse Specialist, Wendy Martin will disc ...
  14. Keynote
    This session will discuss the implications of the 'Integration and Innovation' white paper on cancer care in England, including the vital role of cancer alliances, the implications of changes to speci ...
  15. Improving early detection and diagnosis
10 Jun 2021
  1. Keynote
    Key reflections of the covid pandemic & lessons learnt
  2. Keynote

    This session is sponsored and delivered by Teva UK Limited.

    Teva UK Limited have had no input into the speakers or content for the remaining agenda.

  3. Improving early detection and diagnosis
    As we all know, there is a short window of opportunity to diagnose lung cancer early, as it develops and, in many cases, progresses quickly. A cornerstone of achieving better outcomes for lung cancer ...
  4. Advanced cancer treatments and technologies
    In recent times, there has been unprecedented interest in diagnostic technologies and the benefits they can offer to patients and the NHS. With its recent launch of the new NICE strategy, NICE has ren ...
  5. Transforming cancer care pathways
    For decades, it’s been recognised that the process of noticing a symptom and seeking advice is complex and that people do not always present for medical attention in a timely fashion. This has underpi ...
  6. Keynote
    Presentation on overall survival for patients with BRAF V600E mutant metastatic colorectal cancer. Implications of the BEACON CRC trial and Insights from real-world experience. A recorded webinar from ...
  7. Advanced cancer treatments and technologies
    Whilst there are a number of current and potential game changers, we will look at chimeric antigen receptor T-cells (CAR-T) and neoantigen reactive T-cells (NAR-T).
  8. Advanced cancer treatments and technologies
    A major focus of the NHS Long term plan is to improve cancer survival through prevention, early detection and delivering more personalised therapeutic options and overall care The British Oncology Pha ...
  9. Transforming cancer care pathways
    Developing and delivering an Alliance wide primary care strategy towards the delivery of the NHS Long Term Plan
  10. Advanced cancer treatments and technologies
    Gene-guided clinical management is rapidly becoming the new standard of cancer care in the NHS. The session features prediction of cancer risk, precision diagnosis, drug-metabolizing genotypes, the mo ...
  11. Improving early detection and diagnosis
    The presentation will provide an overview of:Who RM Partners are and the brief/mandate of cancer alliancesThe local context within which RMP works RMP approach to working with and collaborating with p ...
  12. Transforming cancer care pathways
    By 2030, there will be 4m people in the UK living with cancer with over 50% surviving more than 10 years. The high prevalence of physical and psychosocial effects pose important challenges for our hea ...
  13. Keynote
    With the development of Integrated Care Systems, the accelerated collaboration that has come with the Covid response and the evolving idea of ‘Population Health Management’, the opportunities to impro ...

 

 

* OPC is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers. Sessions marked are being delivered with input from the sponsoring company. By attending these sessions you are agreeing to sponsors receiving your registration data. To revoke consent of your details being shared opc@closerstillmedia.com.

Programme correct at time of publication - June 2021.